Stay updated with breaking news from Bio Serv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharma-Bio Serv (OTCMKTS:PBSV – Get Rating) issued its quarterly earnings results on Wednesday. The company reported $0.02 EPS for the quarter, hitting the consensus estimate of $0.02, MarketWatch Earnings reports. Pharma-Bio Serv had a net margin of 6.05% and a return on equity of 6.87%. The firm had revenue of $4.56 million for the quarter, […]
Pharma-Bio Serv Announces Results for the Three and Six Months Ended ...
DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm
Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Rating) was the recipient of a large drop in short interest in April. As of April 30th, there was short interest totalling 400 shares, a drop of 55.6% from the April 15th total of 900 shares. Based on an average daily volume of 5,500 shares, the days-to-cover ratio is […]
Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Rating) was the target of a significant drop in short interest in April. As of April 30th, there was short interest totalling 400 shares, a drop of 55.6% from the April 15th total of 900 shares. Based on an average daily volume of 5,500 shares, the short-interest ratio is […]